Japan's epigenetics market is evolving rapidly, with a strong emphasis on AI-driven research and personalized medicine, addressing complex diseases t ...

Takeda Pharmaceuticals has named Julie Kim as the first woman to lead the 244-year-old Japanese drugmaker, a rarity in senior management in the world’s fourth-largest economy. Kim, a US citizen ...

Innovative national contractor joins BioMed Realty and Takeda to build a state-of-the-art lab and office space in Kendall Square, a hub of global innovation and epicenter of Cambridge’s ...

Takeda has leased the property's approximately 600,000-square-foot of lab and office space, creating a purpose-built research and development facility to deliver life-transforming therapies for ...

(Photo: Business Wire) Innovative national contractor joins BioMed Realty and Takeda to build a state-of-the-art lab and office space in Kendall Square, a hub of global innovation and epicenter of ...

Julie Kim is set to replace Christophe Weber as the new chief executive officer of Takeda Pharmaceutical Co., becoming the first woman to lead the more than 240-year-old Japanese drugmaker.

Suffolk, one of the largest and most innovative real estate and construction enterprises in the country, recently celebrated topping off 585 Kendall. Designed by CBT Architects, 585 Kendall is a ...

Takeda CEO Christophe Weber announced he will step down in 2026 and be replaced by Julie Kim, president of Takeda’s U.S. business unit. As part of the executive transition, Weber will retire in June ...